Austin, Texas-November 18, 2009
TAKE Supply Chain (formerly ClearOrbit) has released Xtended Process Control (X.PC) 5.7d, which is an upgrade to its software that was developed to accelerate and streamline supplier collaboration and extend lean processes by connecting manufacturers and distributors with supply chain partners worldwide to procure goods and services.
TAKE's X.PC 5.7d new features and modules include:
* Web labels, which enable the printing of package tracking numbers (PTN) and advance shipment notice (ASN) labels without a dedicated label printer; * A quick search toolbar, which finds and jumps to POs, invoices, shipments, or quality documents by displaying a list of search results;
* An Engineering Quality Collaboration module to manage the workflow of supplier deviation requests and corrective actions;
* An expanded Accounts Payable module that allows suppliers to create credits as well as invoices, print Invoice PDFs, and view invoice holds; and
* Additional enhancements to existing purchase order and ASN functionality.
“As many corporations turn to collaboration to gain supply chain efficiencies, the speed at which a solution can be used to on-board external entities becomes an important factor,” said Dusty Knight, TAKE Supply Chain vice president of professional services.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.